News | February 23, 2022
Biorchestra announces US$45 million series C fundraising
he financing was significantly oversubscribed with high demand from both existing and new investors.
he financing was significantly oversubscribed with high demand from both existing and new investors.
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
The company has reported total income of Rs.3031 crores during the calendar year ended December 31, 2021.
New biotechnology product aims to be world's fastest automatic sanitary solution
Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
He will continue to lead business in LATAM and Asia regions in this new role
Subscribe To Our Newsletter & Stay Updated
